REFERENCES
1. Tan MY, Syngelaki A, Poon LC, Rolnik DL, O’Gorman N, Delgado JL, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol 2018;52: 186-195.
2. Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, et al. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.Ultrasound Obstet Gynecol 2018; 52: 52-59.
3. Serra B, Mendoza M, Scazzocchio E, Meler E, Nolla M, Sabrià E, et al. A new model for screening for early-onset preeclampsia. Am J Obstet Gynecol 2020; 222: 608.e1-608.e18.
4. Mendoza M, Serrano B, Bonacina E, Capote S, Garcia-Manau P, Regincós L, et al. Diagnostic accuracy of the Gaussian first-trimester combined screening for pre-eclampsia to predict small-for-gestational-age neonates. Int J Gynaecol Obstet. 2021.
5. Mendoza M, Tur H, Garcia-Manau P, Hurtado I, Serrano B, Lopez-Martinez RM, et al. Cut-off values for Gaussian first-trimester screening for early-onset preeclampsia with maternal history, biochemical markers and uterine artery Doppler. J Gynecol Obstet Hum Reprod . 2021; 50: 101827.
6. Mendoza M, Garcia‐Manau P, Arévalo S, Avilés M, Serrano B, Sánchez‐Durán MÁ, et al. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm preeclampsia at 8-10 weeks compared to 11-13 weeks gestation. Ultrasound Obstet Gynecol2021; 57: 84-90.
7. Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ 2016; 353:i1753.
8. Lobo GAR, Nowak PM, Panigassi AP, Lima AIF, Araujo Júnior E, Nardozza LMM, et al. Validation of Fetal Medicine Foundation algorithm for prediction of pre-eclampsia in the first trimester in an unselected Brazilian population. J Matern Fetal Neonatal Med 2019;32: 286-292.
9. O’Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol 2017;49: 756-760.
10. Chaemsaithong P, Pooh RK, Zheng M, Ma R, Chaiyasit N, Tokunaka M, et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.Am J Obstet Gynecol 2019; 221: 650.e1-650.e16.
11. Sonek J, Krantz D, Carmichael J, Downing C, Jessup K, Haidar Z, et al. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.Am J Obstet Gynecol . 2018; 218 : 126.e1-126.e13.
12. Park FJ, Leung CHY, Poon LCY, Williams PF, Rothwell SJ, Hyett JA. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust N Z J Obstet Gynaecol2013; 53: 532-539.
13. Robinson HP, Fleming JE. A critical evaluation of sonar “crown-rump length” measurements. Br J Obstet Gynaecol 1975; 82:702-710.
14. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001;18: 583-586.
15. Carrascosa A, Yeste D, Copil A, Almar J, Salcedo S, Gussinyé M. Anthropometric growth patterns of preterm and full-term newborns (24-42 weeks’ gestational age) at the Hospital Materno-Infantil Vall d’Hebron (Barcelona)(1997-2002). An Pediatr . 2004; 60 : 406–16.
16. Figueras F, Gratacos E. An integrated approach to fetal growth restriction. Best Practice & Research Clinical Obstetrics & Gynaecology . 2017; 38 : 48-58.
17. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice.Hypertension 2018; 72: 24-43.
18. The Fetal Medicine Foundation reasearch tools: calculation of MoMs. https://fetalmedicine.org/research/mom. [May 2019].
19. The Fetal Medicine Foundation reasearch tools: preeclampsia batch risk assessment. https://fetalmedicine.org/research/peRisk. [May 2019].
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
21. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet . 2019;145 Suppl 1:1-33.
22. Oliveira N, Magder LS, Blitzer MG, Baschat AA. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound Obstet Gynecol 2014;44: 279-285.
23. Mazer Zumaeta A, Wright A, Syngelaki A, Maritsa VA, Da Silva AB, Nicolaides KH. Screening for pre-eclampsia at 11–13 weeks’ gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both. Ultrasound Obstet Gynecol 2020; 56: 400-407.